Aurora, CO 的 軟組織肉瘤 臨床試驗
9 項針對 軟組織肉瘤 的研究正在 Aurora（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
招募中1/2 期
- Children's Hospital Colorado - Anschutz Medical Campus, Aurora
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
招募中1/2 期
- University of Colorado Denver, Aurora
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
招募中1 期
- University of Colorado Hospital, Aurora
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
招募中1 期
- UCHealth University of Colorado Hospital, Aurora
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
招募中1 期
- Children's Hospital Colorado, Aurora
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
招募中1/2 期
- Children's Hospital Colorado, Aurora
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
招募中2 期
- University Of Colorado Hospital, Aurora
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
招募中2 期
- Children's Hospital of Colorado, Aurora
其他城市的 軟組織肉瘤 試驗
- Houston, TX32 項研究
- New York City, NY19 項研究
- Boston, MA18 項研究
- St. Louis, MO14 項研究
- Los Angeles, CA13 項研究
- Columbus, OH13 項研究
- Washington, DC12 項研究
- Memphis, TN11 項研究
- Philadelphia, PA10 項研究
- Rochester, MN9 項研究
- Nashville, TN9 項研究
- Queens, NY9 項研究
Aurora 的其他研究
- 癌症（所有類型）35 項研究
- 大腸直腸癌32 項研究
- 非小細胞肺癌30 項研究
- 乳癌27 項研究
- 轉移性癌症25 項研究
- 卵巢癌25 項研究
- 第一型糖尿病23 項研究
- 肥胖症21 項研究
- 肺癌19 項研究
- 前列腺癌19 項研究
- 心臟衰竭18 項研究
- 黑色素瘤18 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。